Mast Cell Activation Syndrome. When your body reacts everywhere and no one says why.
Why this condition is hard to pin down, and why it can be worth looking for possible triggers. What mould, heavy metals, stress, Borrelia and Long COVID may have to do with it. And how functional medicine, PNI and anthroposophic medicine can together open a path forward.
There is a moment in the consulting room when a woman puts her list on the table. Forty symptoms. Six specialists. Three antidepressants. And one sentence that appeared everywhere. All unremarkable.
In my consulting room I keep meeting the same pattern. Complaints in several organ systems at once, skin, gut, circulation, head. Reactions to things others do not even notice, to scents, to certain foods, to changes in temperature. In between, phases in which almost everything seems normal. And a long series of investigations in which nothing unusual was found. I deliberately describe no single course here, no lab values and no treatment success. A pattern is not a diagnosis. From a pattern you can derive neither a cause nor a prognosis for yourself.
I know this picture. Maybe you recognise yourself or someone you love. Multisystemic complaints that no single specialty can place. A diagnosis that no one makes, because it is missing from most textbooks. Or a diagnosis someone has spoken once and which has been used like a label ever since, supposed to explain everything but treating nothing.
Mast Cell Activation Syndrome, or MCAS, is exactly this picture. A young term in medicine. An old suffering in clinics. And a topic that matters to me for two reasons. First, because this picture comes up often in my consulting room. Second, because there is often a story behind MCAS. A story of stress, infections, environmental toxins, connective tissue, trauma. Whoever understands that story can intervene. Whoever does not listen to it only fights symptoms.
What will happen in this text is a journey. We look at what mast cells are. We look at why your body reacts everywhere. We look at what can really stand behind it. And we look at the paths that exist. From functional medicine, from PNI, from an anthroposophically informed perspective. Not as marketing, but as an honest survey of what helps and what does not.
Section 1What mast cells really are
Imagine a small, round cell, packed with hundreds of vesicles. This cell does not sit in your blood. It sits where the world and the body meet. In the skin, in the mucous membranes of nose, lung, stomach, gut, urogenital tract. On the walls of your blood vessels. Around your nerves. These are the mast cells. They have been conserved for over five hundred million years in almost all vertebrates because they are evolutionarily essential.
Their first job is to detect intruders. They carry antennae for bacteria, viruses, fungi, parasites, toxins. As soon as they spot something suspicious, they raise the alarm. This alarm is not only histamine, as many people think. Mast cells release more than two hundred different messengers. Histamine is the most famous. But there is also tryptase, chymase, heparin, prostaglandins, leukotrienes, platelet-activating factor, cytokines like TNF and interleukin 6, and many others.
When a healthy person is stung by a bee, the mast cells do exactly what they were built for. They react locally, briefly and forcefully. Swelling and redness at the sting site, immune cells called in, then they retreat. That is defence. When a healthy person fights a parasitic infection, mast cells are part of the response that keeps the worm load in check. That too is defence.
The problem begins when the mast cell does not stop. When it no longer reacts only to real threats but to many things. To certain foods. To smells. To temperature changes. To stress. To hormonal shifts. To certain medications. To sometimes seemingly nothing at all. When this state becomes chronic and spans several organ systems, we speak of Mast Cell Activation Syndrome.
Mast cells are not your enemies. They are over-awake guards who have at some point been signalled too many threats at once, and who have not slept properly since.
Section 2When your body reacts everywhere at once
One of the biggest challenges for patients and for doctors is that MCAS does not show up in one specialty. It shows up in almost all of them at once. That is not carelessness on the part of colleagues, it is a systems question. Each discipline looks carefully at its own section, and the pattern across all the sections easily falls through. Assembling that pattern takes time that a specialist appointment usually does not have. On top of this, allergy tests are often negative, because many mast cell activations do not run through classical IgE antibodies.
The following list is explicitly not a self-test and not a diagnostic criterion. Almost all of these complaints have many possible causes, most of which have nothing to do with mast cells. It does not replace a medical assessment. It is meant to help you ask better questions in a consultation.
Symptoms by organ system
- Skin. Flushing, sudden redness in the face and on the décolleté, itching, hives, dermographism, eczema, sensitive skin to fabrics and skincare
- Gut. Abdominal pain, bloating, diarrhoea alternating with constipation, nausea, reflux, food intolerances, pain after meals
- Airways. Stuffy or runny nose without a cold, cough irritation, chest tightness, asthma-like episodes
- Cardiovascular. Palpitations without obvious reason, blood pressure swings, dizziness when standing up, syncope, hot and cold flushes
- Nervous system. Brain fog, concentration difficulty, word-finding problems, migraine, insomnia, anxiety, panic, sensory overload
- Musculoskeletal. Joint pain, muscle pain, post-exertional fatigue, hypermobile joints
- Urogenital. Irritable bladder, bladder pain, painful menstruation, worsening before the period, sexual sensitivity changes
- Constitutional. Fatigue, low resilience, weight loss or gain, feeling cold without reason, night sweats
Many women experience a worsening in the second half of the cycle and in menopause. That is no coincidence. Oestrogen can activate mast cells directly. Many people remember a childhood in which everything was normal, and that at some point something big happened. A surgery, an extended stay abroad, a severe infection, a pregnancy, a trauma. After that the body became different. This tipping point is often the most valuable diagnostic detail.
More symptoms does not mean more illnesses. It often means one deep root that reaches into many organ systems at once.
Section 3The diagnosis that falls through the cracks
Medically, MCAS is officially diagnosed when three criteria are met. Multisystemic, mast-cell-mediated symptoms. An objective rise in a mast cell mediator like tryptase in the blood during a flare. And a response to mast cell directed therapy. The strict variant, called consensus-1, requires a tryptase rise of at least twenty per cent plus two nanograms per millilitre above the personal baseline.
The practical problem with this definition is timing. Mast cells release their content in flares. People sitting at the family doctor are usually not in a flare. Tryptase is only briefly elevated during a flare and quickly drops back down. Those without the luck of timing fall through the cracks. The softer variant, consensus-2, allows clinical signs and other mediators like n-methylhistamine in urine. One author group estimates that under this softer definition up to seventeen per cent of the population could be affected. Other professional societies consider MCAS considerably rarer and warn about overdiagnosis. That span is above all a sign that we do not yet know precisely.
What does this span between two and seventeen per cent tell us? It tells us the question is not only biochemical but cultural. Those who look find much. Those who look away find nothing.
An international position paper from 2020 argues that the stricter criteria could exclude many patients who appear clinically affected, and that underdiagnosis is probably the larger problem than overdiagnosis. The author group estimates prevalence at up to seventeen per cent of the population, depending on the criteria used. For context: that is an estimate by this author group, not an epidemiologically measured value. The same paper notes that overdiagnosis under the softer criteria can also become problematic.
Afrin LB et al., Diagnosis 2020. DOI
A 2024 review sharpened the picture. Symptom-only diagnosis without a mediator finding is problematic, and at the same time many patients clinically belong to MCAS without a measurable acute tryptase rise. The research field is in movement.
Gulen T, Curr Allergy Asthma Rep 2024. DOI
A diagnosis you cannot fulfil is not automatically a diagnosis you do not have. Sometimes it is just a diagnosis that has not yet found its language.
When stress lights the mast cell directly
When you live in constant alarm, your brain releases a hormone called CRH, short for Corticotropin-Releasing Hormone. It is classically seen as a precursor of cortisol. But CRH also acts directly on mast cells, because they carry a receptor called CRH-R1. In human nasal mucosal tissue in culture, a 2021 study showed that CRH can stimulate mast cells not only to release but also to multiply. Stress is therefore a signal that can be mapped at cell level, not only a feeling.
Add to this the close contact with the nervous system itself. Mast cells sit directly at nerve endings and at microglia, the immune cells of the brain. When they are chronically active, a state arises that research calls neuroinflammation. This silent inflammation explains brain fog, migraine, sensory overload and sleep disturbance much better than any purely psychological framework.
In polyvagal language mast cell calming belongs to the ventral vagus, the social, safe part of your nervous system. Those who live in sympathetic overdrive keep their guards in permanent alarm. This is where breath, vagal exercise and safe attachment become therapy.
In human nasal polyp tissue in organ culture, and additionally in a mouse model, a 2021 study showed that Corticotropin-Releasing Hormone can increase mast cell numbers and stimulate their degranulation and proliferation. A CRH receptor antagonist blocked the effect. That makes stress a plausible biochemical switch. What was studied was allergic rhinitis, not MCAS, and not the living human being. Whether the same happens throughout the body and in MCAS is not proven by this.
Yamanaka-Takaichi M et al., Int J Mol Sci 2021. DOI
IgE is not everything. Many pathways are much quieter
Classical allergy runs through immunoglobulin E, or IgE. Someone with a peanut allergy makes IgE antibodies against peanut proteins. These antibodies dock onto mast cells, and at the next peanut contact the cell releases its content. This pathway is well known, well testable, well treatable.
In MCAS, IgE often plays only a small role. Most activations run through other pathways. Through complement fragments, through bacterial lipopolysaccharides, through mycotoxins, through heavy metals, through neuropeptides like substance P, through oestrogen, through adenosine, through touch, heat or cold. This is why classical allergy tests are often unremarkable in MCAS, and this is why many doctors say there is nothing to find, even though the patient feels everything.
In PNI we think of mast cells as the gate where innate and acquired immunity meet. They react quickly like the innate system and learn slowly like the acquired one. Those who keep receiving too many stimuli have a gate that never fully closes again.
Section 4The trigger gallery. What can stand behind it
What matters in MCAS is not the label. What matters is the cause. Those who only suppress the mast cell will see it flare again. Those who ask what is upsetting it get a chance for change. In functional medicine we therefore screen seven to eight main categories of triggers. They usually come in combination, rarely alone.
Chronic stress, unresolved trauma, exhaustion
As described, CRH activates mast cells directly. Those living in chronic strain, be it work, caregiving, difficult relationships, unprocessed trauma, keep their mast cells on alert. Early adversity such as a harsh childhood, frequent separations, traumatic surgery or severe illness shapes the stress system for decades. This is not a question of blame. It is a finding.
Infections that never really cleared
Long COVID has stirred up mast cell research in recent years. A 2021 survey found that the reported symptom profile of people with Long COVID and of classical MCAS patients can be very similar. How many people with Long COVID actually meet mast cell mediated criteria is not something this work reports. But Long COVID is only one example. Latent Epstein-Barr virus, chronic Borreliosis, reactivated herpes viruses, Bartonella, Mycoplasma, Candida overgrowth, all can be a quietly burning fire under the mast cells.
An online survey from 2021 compared self-reports from people with Long COVID, from controls and from MCAS patients. The symptom profile and severity of the Long COVID group resembled that of the MCAS group. The research group then hypothesised that a mast cell activation could stand behind some Long COVID pictures. For context: participants were recruited through online support groups and rated their own complaints. That is a hypothesis, not a clinical confirmation.
Weinstock LB et al., Int J Infect Dis 2021. DOI
A 2023 review explains mechanistically how the SARS-CoV-2 spike protein can disturb the blood-brain barrier via mast cells and microglia. About forty-five per cent of COVID sufferers report symptoms months later. That makes mast cell activation a plausible shared endpoint that is currently under discussion.
Theoharides TC, Cells 2023. DOI
Mould and mycotoxins, often from water damage
Those who lived in an apartment with hidden mould sometimes carry the load with them for years. For mycotoxins, the metabolic products of certain moulds like Aspergillus, Stachybotrys or Penicillium, there are laboratory signals that they can activate immune cells. For Ochratoxin A this has been described in human microglia cell lines. Robust human data on mast cells are so far lacking. I name this point because it often fits in practice, and I say just as clearly that the evidence here is thin. Also reported are fatigue, brain fog, breathing problems, frequent infections. In the North American literature the term chronic inflammatory response syndrome or CIRS is used for this picture. The CIRS label is controversial in conventional medicine, and the work on it comes largely from the circle of a single provider. In functional medicine it belongs on the list as soon as the history fits. It is not an established finding.
A small 2014 study by the Shoemaker group compared seventeen patients from the first author's own clinic with eighteen controls and found volumetric differences in two of eleven brain regions examined. For context: the sample is very small, there was no blinding, the first author offers his own CIRS protocol, and the CIRS concept is scientifically contested. No proof can be derived from this work, only a signal worth following up.
Shoemaker RC et al., Neurotoxicol Teratol 2014. DOI
Heavy metals
Mercury from old amalgam fillings, silver, gold, aluminium from certain cosmetics and adjuvants, cadmium from cigarette smoke and industrial exposure, lead from old water pipes. For mercury, gold and silver there are laboratory signals that they can influence mast cells via oxidative stress and via oxidation of certain sulphur groups. These data come largely from cell experiments and animal models. For aluminium, cadmium and lead that data basis is not there. Whether a silent load over years keeps human mast cells permanently on alert is a plausible physiological consideration, but it is not proven in that form. A 2011 review summarises the data on mercury, gold and silver and names them as possible inducers of both mast cell release and autoimmune patterns.
Two things belong here openly. First, removing amalgam can release mercury briefly. Dental practice therefore holds that intact fillings are not removed without reason. If removal is necessary, it should be done with protective measures. That belongs in the hands of your dentist, not in a decision you make alone after a blog article. Second, if a relevant load is suspected, chelation is a possible building block but not a harmless procedure. It can burden mineral balance and the kidneys, it needs close medical supervision, and it is not for self-application. The informative value of the usual mobilisation tests is also assessed differently within the field. That belongs said openly.
A 2011 pharmacological review shows that mercury, gold and silver alter immune responses and activate mast cells. Silver triggers release through Reactive Oxygen Species and via oxidation of thiol groups. Such mechanisms explain why heavy metal exposure can act silently over years, without producing an acute poisoning picture.
Suzuki Y et al., Curr Pharm Des 2011. DOI
Parasites and gut dysbiosis
Evolutionarily mast cells are the antibody-bearing main weapon against worms and protozoa. Without them parasites would have wiped out our ancestors. Yet anyone with a chronic, often unnoticed parasitic burden keeps this system permanently active. Add to that the gut itself. When microbes tip, when the mucosa becomes leaky, when more undigested protein fragments cross the wall, mast cells recognise it as a threat. In stool tests we can find traces. Calprotectin, zonulin, pancreatic elastase, beta-defensin, microbial diversity, parasite PCR.
Hypermobility and connective tissue laxity
Maybe you did the splits as a child without warming up. Maybe you sprain your ankle often. Maybe you dislocate your shoulder in your sleep. This overflexibility has a name, the hypermobile Ehlers-Danlos spectrum. It accompanies MCAS and Postural Orthostatic Tachycardia Syndrome POTS remarkably often. The combination is called the HSD-POTS-MCAS triad. In a retrospective review of one hundred young POTS patients at a single practice, eighty-seven per cent met clinical MCAS criteria. With the strict tryptase definition only two per cent did. This span shows how strongly the chosen definition decides whether a diagnosis becomes possible at all. A 2025 clinical practice update from the American Gastroenterological Association notes that these patients can benefit from H1 and H2 blockers, mast cell stabilisers and elimination diets. Fairness requires what the same document also states: universal MCAS testing is not supported, the strict tryptase rule of twenty per cent plus two nanograms per millilitre applies, and elimination diets should be accompanied by dietary counselling.
A 2025 retrospective chart review of one hundred young patients at a single paediatric cardiology practice shows that the prevalence of MCAS in this POTS group ranges from two to eighty-seven per cent, depending on the definition used. Patients diagnosed on clinical criteria responded to therapy similarly to those diagnosed strictly. That argues for a pragmatic approach, but it does not replace a prospective study.
Yao L et al., Front Neurol 2025. DOI
Histamine-rich food and a tired histamine breakdown
Histamine in food is not the problem if your body breaks it down quickly. The most important breakdown enzyme is diamine oxidase or DAO. It sits in the gut mucosa. Those with a damaged mucosa, chronic inflammation, or certain gene variants, break down food histamine more slowly. What clinically looks like its own disease, histamine intolerance, is often a sibling of MCAS. In the next blog post on vivecura.com I go deep into histamine intolerance. Here it should just become clear that both pictures overlap but are not identical. MCAS is the multisystemic activation of the watchman cell. Histamine intolerance is the impaired breakdown of a single messenger at the gut gate. Those who have both have double work to do.
Environmental chemicals and silent loads
Glyphosate, pesticide residues, plasticisers, PFAS, certain preservatives, microplastics, fragrances, electromagnetic fields. Here the data is thinnest. What I describe at this point is explicitly a clinical observation in individual people, not a body of evidence, and I cannot draw a conclusion from it for you. Some people tell me their complaints improved after changing their surroundings. Whether that is causal I do not know. If everything else has been properly evaluated and you still suffer, a look at your surroundings can still be worthwhile.
Behind MCAS there is often a story no one has asked. The story rarely begins today. It often begins ten, twenty, thirty years ago.
Section 5MCAS and histamine intolerance. Siblings, not twins
Because so many people confuse the two, here is a brief and clear distinction. We will go much deeper into histamine intolerance in the next article.
Histamine intolerance is primarily a gastrointestinal phenomenon. Food histamine is not broken down quickly enough, because diamine oxidase in the gut mucosa is genetically slow, or because the mucosa is chronically inflamed, or because certain medications and alcohol inhibit the enzyme. Symptoms often appear after meals with red wine, aged cheese, cured sausage, fermented foods, tomatoes, spinach, chocolate, fish and seafood. Migraine, skin flushing, abdominal pain, diarrhoea, runny nose, palpitations are typical. A low-histamine diet and, if indicated, DAO supplementation with meals often help.
MCAS is the multisystemic activation of the mast cells themselves. They release hundreds of messengers, not only histamine. Triggers are diverse, the course chronic with flares, the diagnosis more complex, the therapy more multimodal. Those with MCAS often also have histamine intolerance. Those with histamine intolerance do not necessarily have MCAS.
Histamine intolerance is the symptomatology of a single messenger that is not broken down. MCAS is the exhaustion of the watchman cell that releases too many messengers at once. Both deserve understanding, but different paths.
Section 6An anthroposophic lens on the mast cell picture
Anthroposophic medicine looks at the human being differently from conventional medicine. It asks not only what the lab shows but also what the inner warmth is doing. Those who suffer chronically from MCAS often have a disturbed warmth organisation. Some patients describe a sense of cold and at the same time hot flushes, a restless oscillation between freezing and burning. In anthroposophic language the inner human seeks his middle and cannot find it.
Mast cells sit in the boundary tissues. In the skin, in the mucous membranes, in the vessel walls. Connective tissue in the anthroposophic image is the organ that carries warmth and gives form. When connective tissue is soft, overstretched and overstimulated, as in the hypermobile triad, a certain structural force is missing. Mast cells react more strongly than they should in an unbraced space. Anthroposophic medicinal plants traditionally used here work on the warmth and structure level. Yarrow warms and orders the middle. Wormwood brings bile and liver into play. Blackthorn strengthens inner substance after exhaustion. Mistletoe modulates the immune system. Bryophyllum calms and grounds sensory stimuli. Choleodoron supports liver and gallbladder, the central detoxification axis for histamine and other mediators.
Please read this section correctly. None of these remedies has large randomised trials in MCAS. They come from a tradition that takes different paths of knowledge. And they are not harmless teas. Preparations containing greater celandine, such as Choleodoron, can in rare cases strain liver values and belong under medical supervision. Wormwood contains thujone and is not suitable in pregnancy or with seizure disorders. Mistletoe preparations likewise belong in medical hands. I name these remedies because they have their place in my practice, not as a recommendation for self-experiment. They do not replace serious conventional diagnostics. They can be part of a whole treatment.
MCAS is not only a lab finding that fits or does not fit. MCAS is also an experience at the boundary between inside and outside, where the body can no longer tell friend from foe.
Oestrogen, thyroid, and the inner weather
Mast cells carry oestrogen receptors. Many women therefore experience worsening just before the period, when oestrogen is relatively high and progesterone is low. Pregnancy or menopause can also be when MCAS symptoms first appear or massively increase. Progesterone tends to be more stabilising. Important hormonal levers live here.
The thyroid joins in too. Undiagnosed Hashimoto disease can promote mast cell activation through inflammatory mediators. Cortisol from the adrenal gland acutely brakes mast cells, but in chronic alarm the HPA axis derails, and then the natural brake is missing. Those living long in chronic stress lose their own anti-allergic switch.
In PNI we speak of the interplay between nervous system, immune system, metabolism and hormones. It is not a row of separate organs. It is a net that recognises itself in each part and can together tip back or not.
Section 7Therapeutic paths. What three lenses can offer
The therapy of MCAS is multidimensional. There is no single remedy. There are stages, layers, and a long breath. In my practice I sort therapeutic paths into four categories. Conventional medicine in the narrow sense. Functional and PNI substances. Nutrition and microbiome. Lifestyle and anthroposophic support. An honest note on evidence accompanies each point.
Conventional building blocks
H1 antihistamines. Substances like cetirizine, loratadine, bilastine, fexofenadine or desloratadine block the H1 histamine receptor, which mediates skin redness, itching, sneezing and swelling. They are usually the first tool. They also have side effects, for example tiredness, dry mouth or effects on heart rhythm at higher doses, and they can interact with other medications. Which preparation and which dose suits you belongs in a medical conversation. The evidence for the substance class is good, they are a recognised therapy.
H2 antihistamines. Substances like famotidine block the H2 histamine receptor, which mainly influences gastric acid and heart rhythm. They help especially with gastrointestinal symptoms and palpitations. Also established.
Mast cell stabilisers. Cromolyn, also known as cromoglicic acid, is a classical option. Taken orally or locally, it acts directly on the mast cell and reduces its tendency to release. Ketotifen acts antihistaminergic and stabilising at once, with somewhat more sedation. Both belong in a doctor's hands.
Low Dose Naltrexone, LDN. Here it becomes exciting and honest. Naltrexone is actually an opioid blocker, approved at higher doses for addiction. In very low doses it appears to act immunomodulatory, mainly on microglia and certain inflammatory pathways. In MCAS, fibromyalgia, chronic fatigue and autoimmune conditions many patients report clear improvements. Honest framing matters. LDN in MCAS is off-label. The evidence consists of smaller studies and especially clinical experience. It is not for everyone and requires medical guidance. Important and often overlooked: naltrexone is not suitable during ongoing opioid therapy and can trigger withdrawal. Anyone considering it should discuss it with someone experienced and disclose all current medications.
Anti-IgE therapy and biologicals. Omalizumab, an antibody against IgE, has shown good effect in individual studies and case series for severe MCAS. It remains a specialist option. Other biologicals are currently being investigated.
Functional and PNI substances
Please read this first
What follows is a look at the research landscape, not a recommendation and not an instruction for taking anything. Food supplements are foods. They are legally not intended to treat a disease, and I describe here only what is being researched. Whether and what could make sense in your case belongs in a personal conversation.
Plant substances and vitamins have side effects and interactions too. A few examples that often get lost. Bromelain, curcumin and omega 3 can affect blood clotting and matter with anticoagulant medication and before surgery. High-dose vitamin C is not readily suitable with kidney disease, kidney stones or G6PD deficiency. Magnesium belongs under medical supervision with impaired kidney function. High-dose EGCG from green tea and high-dose curcumin are not suitable with liver disease without medical assessment. In pregnancy and breastfeeding, and in children and adolescents, almost everything named here applies only after medical consultation. And please do not stop anything that was prescribed to you on your own.
I sort the substances by what is being researched. Evidence for each point varies widely. Some are described in many cell studies and single human studies. Others are primarily clinical experience.
Quercetin. A flavonoid from onions, apples, capers, parsley. In cell cultures it can inhibit histamine release from mast cells, and it also acts as an antioxidant. The data come largely from cell experiments and from small, unblinded clinical work. On MCAS itself there are no robust studies.
Luteolin. A closely related flavonoid, described as particularly interesting by the Theoharides research group. In cell experiments it appears to calm both mast cells and microglia. The evidence is mostly preclinical. In fairness this belongs with it: the researcher these works rest on has a commercial interest in luteolin-containing preparations. That does not devalue the data, but you should know it.
Rutin. Another flavonoid, often combined with quercetin. Stabilises blood vessels and can modulate mast cells.
Vitamin C. There are studies in which vitamin C accelerated histamine breakdown. A chronically low vitamin C status could slow that breakdown. Vitamin C also acts as an antioxidant. In functional medicine it is also used as an infusion. That is a medical application with its own prerequisites and its own limits.
Vitamin D. Not only a bone vitamin. It modulates the immune system and correlates inversely with allergic activity in observational studies. Whether a level in the lower normal range should be raised is a medical decision in each individual case.
Magnesium. Cofactor in hundreds of enzymes, calms the nervous system, may indirectly stabilise mast cells. Many MCAS patients are low in magnesium, often with calf cramps, restless legs and irritability.
Zinc. Important for immune balance, mucosal regeneration and also DAO activity. Deficiency is common.
Vitamin B6 and copper. Diamine oxidase needs B6 as cofactor and copper as central atom to break down histamine. Subtle shortage here can generate much symptomatology.
Diamine oxidase as a supplement. Given before histamine-rich meals in proven histamine intolerance, it can ease acute symptoms. Effect is in the gut, not systemic. The data base is growing but still in motion.
Bromelain. Enzyme from pineapple, anti-inflammatory, can support mucosal regeneration. Often combined with quercetin.
Curcumin and Boswellia. Plant-based inflammation moderators. Bioavailability matters, so liposomal or phytosomal forms.
Omega-3 fatty acids. From fish or algae oil. Provide the substrate for resolvins, the body's own resolving signals. Often low in MCAS.
Black seed oil, Nigella sativa. Contains thymoquinone, which shows antiallergic and antihistaminergic properties in studies. Widely used clinically in functional medicine with positive experience.
EGCG from green tea. Polyphenol with anti-inflammatory action, interesting in mast cell research.
N-acetyl-cysteine and glutathione. Antioxidant heavyweights, help against oxidative stress that fuels mast cells. Especially relevant in heavy metal load and chronic toxin exposure.
Methylation nutrients. Methylcobalamin, methylfolate, trimethylglycine. Help methylate histamine and thus break it down. Especially relevant with MTHFR gene variants.
Probiotics with histamine-degrading strains. Bifidobacterium infantis, Bifidobacterium longum, Lactobacillus rhamnosus GG, certain Streptococcus strains break down histamine in the gut. Some strains produce histamine. The choice must be careful.
An honest note. Much of what I list here has no large randomised trials specifically for MCAS. The evidence is a mosaic of cell experiments, small human studies and clinical experience. I claim nothing. I offer to test together what could work for you.
A 2012 study compared quercetin with cromoglicic acid in cultured human mast cells. Quercetin inhibited the release of histamine and several inflammatory messengers there. The authors additionally describe two small open pilot trials in contact dermatitis and photosensitivity. The available data come overwhelmingly from cell cultures. What happens in a cell culture says nothing yet about what happens in a human being. The two pilot trials were small, open and unblinded, and they had nothing to do with MCAS.
Weng Z et al., PLoS One 2012. DOI
Nutrition and microbiome
A low-histamine trial period. For four to six weeks, histamine-rich, histamine-liberating and biogenic-amine-rich foods are reduced. Freshly prepared, freshly bought, quickly eaten. Aged cheese, cured sausage, red wine, beer, fermented products, aged meat, tomatoes, spinach, avocado, sauerkraut, soy sauce, chocolate, strawberries, citrus can be reduced in this phase. This diet is a tool for a limited time, not a life model. Please do not do it alone and not permanently, but with medical or dietetic guidance. For children, pregnant women, underweight people and anyone with a history of an eating disorder, an elimination diet without guidance is not suitable. If clear improvement appears after four to six weeks, that is a hint. Then we expand step by step, individually tolerated.
Mucosal regeneration. L-glutamine, mucilaginous substances like slippery elm and marshmallow, polyphenols, bone broth can nourish the mucosa. Avoiding gluten and industrial plant oils may help in those who are sensitive.
Hydration. Mineral-rich still water, small sips, sufficient but not exaggerated.
Lifestyle and vagal work
Here lie levers no one takes for you and no one can prescribe for you.
Breath. Long exhalation, five seconds in, seven seconds out. Humming. Gargling. Singing. All activate the ventral vagus.
Sunlight and oxygen. Twenty minutes of morning natural light without sunglasses. This stabilises circadian rhythm and with it cortisol and histamine.
Movement within your capacity. Walks, yoga, Qigong, gentle strength training. For some patients intense movement initially triggers, because effort itself can activate mast cells. Patience is key.
Heat with caution. Sauna helps some and triggers others. Infrared is often better tolerated. Yarrow oil liver compresses are an anthroposophic measure with a calming effect on the middle.
Sleep. Seven to nine hours, dark room, clear bedtime, no screens in the last minutes. In sleep microglia regulate, and there the mast cell system calms too.
Stress and trauma work. Here lies the decisive lever for many. Those who had to carry too much too early in childhood trained their mast cells literally young. Polyvagal exercises, Somatic Experiencing, EMDR, IFS, mindfulness-based therapy can release deep traces.
Anthroposophic support
Yarrow, Choleodoron, Bryophyllum, mistletoe, Hepatodoron for the liver, Cardiodoron for the middle. These remedies come from a tradition I respect and which has its place in my practice. I promise nothing. I offer them as an additional layer in a treatment plan that speaks several languages.
Therapy in MCAS is never a single remedy. It is a composition of several instruments that together learn to play a quieter piece.
Section 8Differentiate, do not oversimplify
A good article must also say where MCAS does not fit. Not every complex symptom mix is MCAS. The following diagnoses must be considered, some need to be ruled out or confirmed first. This matters: that assessment takes precedence over any self-experiment with diet, supplements or breathing exercises. Some of these diagnoses are time critical.
Systemic mastocytosis. A rare clonal mast cell disease with elevated baseline tryptase. Needs haematological evaluation.
Hereditary alpha-tryptasemia. A genetic variant with raised tryptase, present in a small percentage of the population, which can amplify MCAS-like symptoms.
Classical IgE allergies. They should be tested, especially with clear triggers.
Carcinoid syndrome. A rare neuroendocrine tumour with flushing and diarrhoea. Must be ruled out in atypical courses.
Hyperthyroidism. Can cause palpitations, sweating and irritability. Belongs in the basic workup.
Phaeochromocytoma. Very rare but important to rule out in attack-like hypertension with sweating.
Functional dyspepsia and irritable bowel syndrome. Overlap with MCAS. Some of these patients are actually MCAS patients, some are not.
Psychiatric conditions. Anxiety and panic disorders can present biologically similar. They can coexist or be a consequence of unrecognised MCAS. They deserve their own language and their own therapy.
A diagnosis is not a sign over your door. It is a map for a specific region. Some regions overlap. A good doctor knows in which one you are right now, and which others you might still travel through.
Important, before you read on
If you experience shortness of breath, swelling of the tongue or lips, tightness in the throat, a sharp drop in blood pressure or a loss of consciousness, that is an emergency. Then it is 112, the European emergency number, and not waiting. Anyone who has had such reactions should clarify with a doctor whether an emergency kit with an adrenaline auto-injector is needed. Nothing further in this text replaces that.
And if you are in severe emotional distress or thinking about suicide: turn to medical help immediately, call 112, or in Germany the Telefonseelsorge crisis line on 0800 111 0 111.
Section 9What you can do now
You have read this far. You are probably tired, probably hopeful, probably both. Here is a concrete guide to what you can set in motion yourself before coming to a specialist consultation. These steps do not replace medical advice. They give us a better starting point.
Six steps you can take now
Each of these steps gathers a piece of the puzzle. Together they paint a picture that most fifteen-minute family doctor visits cannot draw.
- Keep a symptom diary for two weeks. Note daily sleep, stress, menstrual phase, meals, environmental exposure, symptoms. You will see patterns that help the practice immediately.
- Make an honest inventory of your trigger history. When did it start? What was going on then? Were there water damages in the home? Amalgam fillings? Severe infection? COVID? A difficult life phase? A major surgery? Gather a timeline and concrete events.
- Talk about a low-histamine phase of four to six weeks. It can give hints. It is a tool for a limited time and not a life model. Please do not do it alone and not permanently, but with medical or dietetic guidance. For children, pregnant women, underweight people and anyone with a history of an eating disorder, an elimination diet without guidance is not suitable.
- Breathe consciously every day. Three times seven minutes. Four seconds in, seven seconds out. With this you address your vagus, the calming part of your nervous system. There are signals that a calmer nervous system may also irritate mast cells less. It costs nothing, it does no harm, and it is a lever you hold yourself.
- Bring the following lab work to the practice. Blood tryptase, plasma histamine, n-methylhistamine in 24-hour urine, serum diamine oxidase, eosinophil cationic protein, total and specific IgE if history fits. Full blood count, differential, ferritin, vitamin D, vitamin B12, folate, magnesium, zinc, copper, selenium. TSH, free T3, free T4, TPO and TG antibodies. Calprotectin and zonulin in stool, parasite PCR in stool. If mould suspected, urine mycotoxins and ideally a professional home inspection. If heavy metal suspected, whole-blood mineral panel with mercury, lead, cadmium. With suspected chronic infections, Borrelia serology, EBV reactivation markers, and if indicated Bartonella and Mycoplasma. This list is a stock, not an order. What of it makes sense in your case is decided only after the conversation. And quite openly: for some of these investigations, for example stool zonulin or urine mycotoxins, the informative value is contested within the field. I use them as a puzzle piece, never as proof.
- Until then treat yourself not as a patient but as a researcher. You are gathering data about yourself. You observe. You hold off hard conclusions until the picture stands together. That is the only attitude that works long term with MCAS.
Section 10And now you know why
What remains at the end? Not a recipe, but a stance. If a trigger stands behind a mast cell picture, then it is worth looking for it. That rarely happens in one step and rarely quickly. It happens step by step, in an order your body can follow. Which building blocks come into question for whom belongs in a personal conversation, not in a blog article. I cannot promise you an outcome. I can promise you that I ask before I treat.
You are not too complicated. You are not too sensitive. You are not imagining this. Your body is doing something that has its place in medical literature, but does not receive enough time in most consultations. You need someone who asks the right questions, listens well, and builds a plan that fits your story. And at the same time: a psychiatric diagnosis is not a siding. Anxiety, depression and exhaustion can exist alongside a physical finding, and they deserve their own good treatment. Please do not stop anything on your own, neither antidepressants nor acid blockers nor other prescribed medication.
True freedom is not being symptom-free. True freedom is trusting your body again, that it has a reason to react the way it does. And finding that reason together.
In the next article on vivecura.com I look deeply at histamine intolerance. Those who recognise both can orient themselves better. Those who confuse them fight on the wrong front. Until then, breathe. You are not alone. This picture of symptoms is described, and there are approaches that can help many people. How much is possible for you can only be said once we have looked together.
Sources
- Afrin LB et al. Diagnosis of mast cell activation syndrome. A global consensus-2. Diagnosis (Berl) 2020. doi.org/10.1515/dx-2020-0005
- Gulen T. Mast Cell Activation Syndromes. Diagnostic Challenges and 2024 Update. Curr Allergy Asthma Rep 2024. doi.org/10.1007/s11882-024-01126-0
- Weinstock LB et al. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis 2021. doi.org/10.1016/j.ijid.2021.09.043
- Theoharides TC, Kempuraj D. Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID. Cells 2023. doi.org/10.3390/cells12050688
- Yamanaka-Takaichi M et al. Stress and Nasal Allergy. CRH stimulates mast cell degranulation. Int J Mol Sci 2021. doi.org/10.3390/ijms22052773
- Hagiwara SI et al. Stress-induced CRF in colonic mast cells. PLoS One 2018. doi.org/10.1371/journal.pone.0203704
- Suzuki Y et al. Heavy metals and mast cell activation. Curr Pharm Des 2011. doi.org/10.2174/138161211798357917
- Yoshimaru T et al. Silver activates mast cells through reactive oxygen species. Free Radic Biol Med 2006. doi.org/10.1016/j.freeradbiomed.2006.01.023
- Shoemaker RC et al. Structural brain abnormalities in patients exposed to water-damaged buildings. Neurotoxicol Teratol 2014. doi.org/10.1016/j.ntt.2014.06.004
- Dooley M et al. Chronic Inflammatory Response Syndrome. A literature review. Ann Med Surg 2024. doi.org/10.1097/MS9.0000000000002718
- Yao L et al. Association of postural orthostatic tachycardia syndrome, hypermobility spectrum disorders, and mast cell activation syndrome in young patients. Retrospective chart review. Front Neurol 2025. doi.org/10.3389/fneur.2025.1513199
- Aziz Q et al. AGA Clinical Practice Update on Joint Hypermobility Spectrum Disorders. Clinical practice update without formal evidence grading. Clin Gastroenterol Hepatol 2025. doi.org/10.1016/j.cgh.2025.02.015
- Schnedl WJ, Enko D. Histamine Intolerance Originates in the Gut. Nutrients 2021. doi.org/10.3390/nu13041262
- Mukai K et al. Mast cells as sources of cytokines, chemokines, and growth factors. Semin Immunopathol 2016. doi.org/10.1007/s00281-016-0565-1
- Weng Z et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One 2012. doi.org/10.1371/journal.pone.0033805
- Tsilioni I, Kempuraj D, Theoharides TC. Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia. Int J Mol Sci 2025. doi.org/10.3390/ijms26020636
This article serves educational purposes and does not replace personal medical advice, diagnosis or therapy. Changes to medications or supplements should only be made in consultation with a physician. Please do not stop anything on your own. In case of shortness of breath, swelling in the mouth or throat, circulatory collapse or loss of consciousness, call the emergency number 112. Off-label uses such as LDN, functional substances without large randomised trials, and anthroposophic support are explicitly marked as such. Written by Shukri Jarmoukli, ViveCura private practice, Berlin.